All these data strongly suggest that the c.*1043A>C mutation may have a role in the pathogenesis of CF, impairing the regulation of gene expression, and thus acting as a mild causing disease mutation, since CFTR-RD patients typically are compound heterozygous for a severe and a mild CFTR mutation [5]. The gene discussed is CFTR; the disease is cystic fibrosis.